Lorenzo Gasperoni

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Radical Prostatectomy

Top Venues

Current oncology (Toronto, Ont.)

Expert opinion on drug metabolism & toxicology

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Ossato, Lorenzo Gasperoni, Luna Del Bono, Andrea Messori, Vera Damuzzo
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival. Cancers 16 (3) (2024)
Lorenzo Gasperoni, Carla Masini, Giada Toscano, Alessandro Cafaro, Chiara Zani, Cristina Andrianò, Paolo Silimbani, Caterina Donati, Giorgia Bortolin, Sara Cecco
Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials. Current oncology (Toronto, Ont.) 31 (5) (2024)
Andrea Ossato, Lorenzo Gasperoni, Luna Del Bono, Andrea Messori, Vera Damuzzo
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival. Cancers 16 (3) (2024)
Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Emilio Francesco Giunta, Andrea Messori, Vera Damuzzo
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy? Cancers 16 (13) (2024)
Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Emilio Francesco Giunta, Andrea Messori, Vera Damuzzo
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy? Cancers 16 (13) (2024)
Lorenzo Gasperoni, Carla Masini, Giada Toscano, Alessandro Cafaro, Chiara Zani, Cristina Andrianò, Paolo Silimbani, Caterina Donati, Giorgia Bortolin, Sara Cecco
Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials. Current oncology (Toronto, Ont.) 31 (5) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology (2024)
Lorenzo Gasperoni, Carla Masini, Giada Toscano, Alessandro Cafaro, Chiara Zani, Cristina Andrianò, Paolo Silimbani, Caterina Donati, Giorgia Bortolin, Sara Cecco
Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials. Current oncology (Toronto, Ont.) 31 (5) (2024)
Lorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, Carla Masini, Ugo De Giorgi
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Lorenzo Gasperoni, Alessandro Cafaro, Eleonora Ferretti, Valentina Di Iorio, Oriana Nanni, Carla Masini
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure. European journal of hospital pharmacy : science and practice (2022)